{"id":"W2591556663","doi":"10.1200/jco.2012.30.4_suppl.240","title":"Preclinical study of MEK1/2 inhibitor AZD6244 combined with gemcitabine for treatment of biliary cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Gemcitabine; Clonogenic assay; Cancer research; In vivo; Cancer; Medicine; Cell cycle; Cancer cell; Cell growth; Pharmacology; Internal medicine; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002882432,0.0005950131,0.0008152747,0.0004730744,0.0002245107,0.0003092964,0.0003725238,0.0003726425,0.00160548],"category_scores_gemma":[0.0001604514,0.000253989,0.000417796,0.0003361085,0.0002301628,0.0002609138,0.000187969,0.0007950482,0.0003285567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003496012,"about_ca_system_score_gemma":0.0005916413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007663001,"about_ca_topic_score_gemma":0.001722239,"domain_scores_codex":[0.9998786,0.00004033506,0.000009637113,0.00001812082,0.00002266183,0.00003062274],"domain_scores_gemma":[0.9998832,0.00001758672,0.00002385867,0.00001332833,0.0000136243,0.00004841781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01821823,0.01501416,0.001689966,0.000570169,0.0002812563,0.0002973831,0.0001601882,0.002409052,0.9206254,0.0002864264,0.001456551,0.03899115],"study_design_scores_gemma":[0.004788876,0.2362764,0.01211902,0.0000497519,0.0005656476,0.0007607644,0.00008325077,0.00363092,0.7313511,0.0001297288,0.01021437,0.00003016644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937092,0.003151316,0.0005988473,0.000166289,0.00008032426,0.0003001322,0.0004912876,0.00008864509,0.001413898],"genre_scores_gemma":[0.9921106,0.0030934,0.001374941,0.00008585786,0.00003605887,0.000279968,0.001131068,0.0000199184,0.001868267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00160548,"threshold_uncertainty_score":0.005370855,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2240536777639899,"score_gpt":0.5011278258308577,"score_spread":0.2770741480668678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}